Friday, May 8, 2026

Bitcoin Wavers on U.S. Tariff Jitters—Dips to $83K Before Rebounding

Bitcoin fluctuates amid U.S. tariff confusion, while a survey reveals one in five Americans own cryptocurrency.

GC Biopharma Develops Innovative Method to Enhance Immunoglobulin Safety

GC녹십자 developed a method to detect impurities that can cause blood clots in the production of intravenous immunoglobulin.

The Coward’s Law: South Korea’s Government Blocks ALL Aid To Starving Citizens

The National Assembly passed an amendment to the Aviation Safety Act, banning unmanned balloons in no-fly zones, sparking political debate.

Tag: ALYGLO

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

Top News

- Our Sponsors Ad -

Follow us